V E Steele - JoVE Visualize

Showing results (101-110 of 132) with videos related to

Pageof 14

Sort By:

Expert Opinion on Investigational Drugs|November 4, 2000

Potential use of lipoxygenase inhibitors for cancer chemopreventionV E Steele, C A Holmes, E T Hawk, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovaryG J Kelloff, C W Boone, J A Crowell, et al.

Carcinogenesis|August 30, 2000

Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colonK Yang, S A Lamprecht, Y Liu, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996

Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the ratM J Wargovich, C D Chen, A Jimenez, et al.

Oncology (Williston Park, N.Y.)|October 1, 1996

Strategies for identification and clinical evaluation of promising chemopreventive agentsG J Kelloff, E T Hawk, J A Crowell, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999

Lipoxygenase inhibitors as potential cancer chemopreventivesV E Steele, C A Holmes, E T Hawk, et al.

Anticancer Research|January 1, 1993

Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumorsC J Grubbs, M M Juliana, I Eto, et al.

European Journal of Cancer (Oxford, England : 1990)|June 5, 2004

Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studiesK T Christov, R C Moon, D D Lantvit, et al.

Seminars in Oncology|April 1, 1997

Progress in clinical chemopreventionG J Kelloff, E T Hawk, J E Karp, et al.

Nutrition and Cancer|January 1, 1997

Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesisM A Morse, L A Kresty, V E Steele, et al.

Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:

Pageof 14

Expert Opinion on Investigational Drugs|November 4, 2000

Potential use of lipoxygenase inhibitors for cancer chemopreventionV E Steele, C A Holmes, E T Hawk, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovaryG J Kelloff, C W Boone, J A Crowell, et al.

Carcinogenesis|August 30, 2000

Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colonK Yang, S A Lamprecht, Y Liu, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996

Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the ratM J Wargovich, C D Chen, A Jimenez, et al.

Oncology (Williston Park, N.Y.)|October 1, 1996

Strategies for identification and clinical evaluation of promising chemopreventive agentsG J Kelloff, E T Hawk, J A Crowell, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999

Lipoxygenase inhibitors as potential cancer chemopreventivesV E Steele, C A Holmes, E T Hawk, et al.

Anticancer Research|January 1, 1993

Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumorsC J Grubbs, M M Juliana, I Eto, et al.

European Journal of Cancer (Oxford, England : 1990)|June 5, 2004

Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studiesK T Christov, R C Moon, D D Lantvit, et al.

Seminars in Oncology|April 1, 1997

Progress in clinical chemopreventionG J Kelloff, E T Hawk, J E Karp, et al.

Nutrition and Cancer|January 1, 1997

Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesisM A Morse, L A Kresty, V E Steele, et al.

Pageof 14